Skip to main content
MCHX $1.85 +1.65%
MCHX logo

MCHX · Marchex Inc

Track MCHX — free
$1.85 +0.03 (+1.65%) At close · Aug 14
Market Cap
$77.53M
Shares
44.34M
All earnings calls

Earnings call · FY2026 Q1

Marchex Inc Q1 FY2026 Earnings Call

Marchex Inc Q1 FY2026 Earnings Call

Concluded May 13, 2026 Audio replay
May 13, 2026 22:45 19 turns
Period
FY2026 Q1
Runtime
22:45
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Marchex reported Q1 2026 GAAP revenue of $10.6 million (down from $11.4M year-over-year) with an adjusted EBITDA loss of $0.1M, but raised Q2 adjusted EBITDA guidance to $1.6–$1.8M and signaled Q3 standalone adjusted EBITDA could reach ~$2M or more, citing encouraging early adoption of bundled AI products being co-developed with Arcania.

Proposed Arcania acquisition and collaboration 24 Financial guidance and outlook (revenue and EBITDA) 19 Sales momentum and customer adoption (top 100) 9 Vertical market focus and verticals expansion 9 AI-driven product opportunity and bundled solutions 7 Long-term $100M revenue opportunity and capital allocation 5

Management tone

Confident

Net tone +72 · low hedging

Grounding quotes
  • “we believe the company is crossing a positive inflection point, both strategically and operationally”
  • “we have seen very encouraging initial adoption”
  • “we are now in a strong position with our ability to leverage new AI capabilities across the customer acquisition and optimization journey”

Forward guidance

6 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $10.62M -6.9% YoY
Diluted EPS -$0.04
Net income -$1.72M

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Raised Q2 2026 adjusted EBITDA guidance to $1.6–$1.8M, up from prior guidance of more than $1.0M
  • Initial Q3 2026 standalone adjusted EBITDA guidance of ~$2M or more
  • Nearly a third of top 100 customers have been pitched bundled Arcania/Marchex AI products, with approximately half already purchasing on a recurring or paid pilot basis
  • New products showing potential to roughly double revenue on a per-customer basis
  • Lowered recurring cost structure from 2025 realignment expected to drive gross profit margin and operating leverage improvements
  • Net loss narrowed to $1.7M ($(0.04)/share) from $2.0M ($(0.05)/share) a year earlier

Risks & pressure points

  • Q1 2026 revenue of $10.6M declined from $10.8M in Q4 2025 and from $11.4M in Q1 2025
  • Q1 2026 adjusted EBITDA was a loss of $0.1M (including $0.7M of reorganization and acquisition-related costs)
  • Cash declined to $9.0M from $9.9M at end of Q4 2025 due to annual payroll and severance payments
  • Legacy platform migration activities negatively impacted revenue run rates entering 2026
  • Arcania transaction has not yet closed, creating execution dependency for combined-company guidance and product roadmap

Key moments

Jump directly to management's words in the synchronized transcript.

Forward guidance

From the 8-K filed May 13, 2026.

Metric Guided
Adjusted EBITDA
second quarter of 2026
$1.6M – $1.8M
Revenue growth (run rate basis)
over the course of 2026
10%

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Adjusted EBITDA annualized run rate
third quarter of 2026
at least $10M
Revenue growth on a run rate basis
course of 2026
10%
Revenue run rates
course of 2026
$60M
Revenue growth
course of 2026
15% – 20%
Full-screen source Call document